Advances in Heterocyclic Derivatives for Aromatase Inhibition in Hormone-Dependent Breast Cancer.

Kaur H, Kaur K, Singh G.

Open source

DOI
10.2174/0115680266452626260702092804
Published
2026-07-17
Container
Curr Top Med Chem
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2174/0115680266452626260702092804,
  title = {Advances in Heterocyclic Derivatives for Aromatase Inhibition in Hormone-Dependent Breast Cancer.},
  author = {Kaur H and  Kaur K and  Singh G.},
  year = {2026},
  journal = {Curr Top Med Chem},
  doi = {10.2174/0115680266452626260702092804},
  url = {https://doi.org/10.2174/0115680266452626260702092804}
}

RIS

TY  - JOUR
TI  - Advances in Heterocyclic Derivatives for Aromatase Inhibition in Hormone-Dependent Breast Cancer.
AU  - Kaur H
AU  -  Kaur K
AU  -  Singh G.
PY  - 2026
JO  - Curr Top Med Chem
DO  - 10.2174/0115680266452626260702092804
UR  - https://doi.org/10.2174/0115680266452626260702092804
ER  - 

APA

H, K., K, K., & G., S. (2026). Advances in Heterocyclic Derivatives for Aromatase Inhibition in Hormone-Dependent Breast Cancer.. Curr Top Med Chem. https://doi.org/10.2174/0115680266452626260702092804

Source records